TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
VCRE

Vicore Pharma Holding AB

Healthcare · Biotechnology

9.50$ -0.1% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Vicore Pharma Holding AB (VCRE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 1,219 million SEK. Tick rows to compare them in a chart.

All figures in millions of SEK.

Tick rows to compare them in a chart (up to 4)

Balance Sheet VCRE
Line item 2022 2023 2024 2025
338 498 1,196 1,219
270 496 1,196 1,217
257 334 1,156 578
68 2.2 – –
49 42 66 123
46 41 66 118
23 18 30 39
289 455 1,129 1,095
-963 -1,274 -1,442 -1,921
84 115 235 282

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?